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ABSTRACT
We recently found that the proteins of the proteolytic system of plas­
minogen activation emerge in late stages of melanocytic tumor progres­
sion. A large body of evidence suggests a role for two proteins, the 
low-density lipoprotein receptor-related protein (LRP)/as-macroglobulin 
receptor and its receptor-associated protein (RAP), in the internalization 
of components of the plasminogen activation system. Here, we present 
data on thr presence of these two proteins in human melanoma cell lines 
which diffe * in metastatic capacity, their corresponding xenografts, and in 
cutaneous Melanocytic lesions.
With flovr cytometry, we found surface expression of LRP to be re­
stricted to u rokinase plasminogen activator, producing highly metastatic 
cell lines. These cell lines also produce higher levels of LRP mRNA, 
whereas RA.’P mRNA and protein are expressed at equal levels in all cell 
lines and not expressed at the cell surface. Xenografts of cell lines pro­
ducing high levels of LRP remarkably contain only a small fraction of 
LRP-positive tumor cells.
Using immunohistochemistry on frozen sections of 107 human melano­
cytic lesions comprising the various stages of melanocytic tumor progres­
sion, we found that expression of both LRP and RAP decreased in tumor 
progression. Furthermore, we noted that LRP and RAP are coexpressed 
within the same lesion. Using immunofluorescence double staining, we 
found that LRP and RAP colocalize in the same cells in the lesions studied 
and in the same cell structures in the cell lines studied. In conclusion, our 
results indicate that LRP and RAP are coordinately expressed in a de­
creased fashion in melanocytic tumor progression. Based on the staining 
results in xenografts and in human melanocytic lesions, we conclude that 
a strong correlation between expression of LRP and urokinase-type plas­
minogen activator seems not to exist in in vivo melanomas.
INTRODUCTION
The transition from normal melanocytes to melanoma cells in­
volves distinct changes in the protein repertoire of these cells (I). 
Among others, proteases are elevated in malignant stages of mela­
noma (2). In recent years, it has become dear that the inactivation of 
such proteins is a tightly regulated process. Two proteins involved in 
the clearance and cellular uptake of inactivated proteases are the 
LRP3/a2-macroglobulin receptor, also known as CD91, and its RAP.
LRP is a member of the low-density lipoprotein receptor family 
(reviewed in Refs. 3 and 4). The gene encoding the enormous protein 
comprises 89 exons (5), revealing a 15-kb mRNA transcript, from
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which a Mr 600,000 precursor protein is translated, which is cleaved 
into a Mr 515,000 a chain and a Mr 85,000 jS chain. Apart from 
activated complexes of o:2-macroglobulin, many other ligands can be 
internalized upon binding to LRP, including ApoE and various pro­
teins or complexes of proteins of the plasminogen activation system 
(reviewed in Ref. 6). t-PA can bind to LRP (7) and complexes of t-PA 
with PAI-1 can be internalized mediated by LRP (8). LRP-mediated 
internalization of complexes of u-PA with inhibitors occurs most 
efficiently when u-PA is bound to its receptor u-PAR (9-12).
RAP is a Mr 39,000 protein which copurifies with LRP and other 
members of the low-density lipoprotein receptor family (13). RAP is 
restricted to the en do plasmatic reticulum and serves as a chaperone 
for LRP (14, 15). By binding to LRP, RAP can prevent binding of all 
other known ligands, including (complexes of) plasminogen activators 
(16-19).
In human tissues, LRP and RAP are mainly expressed in the 
placenta, liver, and nervous tissues (20-23). Colocalization of LRP 
and RAP has been described for glioblastoma cells (24) and human 
trophoblasts (25).
Little is known about LRP and RAP expression in human tumor 
cell lines or in human tumors. In human tumor cell lines, it seems that 
LRP expression decreases with aggressiveness: (a) tumor cells make 
no or less receptor for a2-macroglobulin when compared to nontumor 
cell lines (26-29); (b) LRP is present in photodynamic therapy- 
sensitive tumor cells and not in therapy-resistant cells (30); and (c) 
invasive cells make less LRP than noninvasive cells (31). In human 
tumors, LRP was detected in glioma cells (32), but is decreased or 
absent in malignant lymphomas (33) and hepatocellular carcinomas 
(34). We previously described the presence of the components of the 
plasminogen activation system in human melanoma cell lines (35) and 
in human melanocytic lesions (2). Expression of u-PA and PAI in 
human melanoma cell lines correlated with metastatic capacity in 
nude mice (35). In human lesions, the components of the plasminogen 
activation system are only expressed in the later stages of malignancy 
(2, 36). In this study, we investigated the presence of LRP and RAP, 
two proteins involved in the internalization of components of the 
plasminogen activation system in 7 human melanoma cell lines and 
107 human cutaneous melanocytic lesions.
MATERIALS AND METHODS
Melanoma Cell Lines. Melanoma cell lines 530, 1F6, M14, Mel57, BLM, 
and MV3 have been used before. Previously, a correlation could be established 
between the metastasizing capacity of the BLM and MV3 cell lines and their 
production of u-PA and PAI (35). From IF6 a subline, IF6-m, has been 
isolated. This subline is mctastatic when injected s.c. into nude mice.4 A 
primary culture of human foreskin fibroblasts (flow cytometry and iminuno- 
\fluorescence double labelings) and rat fibroblasts (mRNA analysis) served as 
a positive control for LRP (26).
Xenografts in Nude Rats. Two X 106 cells of melanoma cell lines lF6-m 
and BLM were injected s.c. in nude rats. The animals were sacrificed when the
Westphal et ai., manuscript in preparation.
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tumor had a diameter of approximately 1 cm. A part of the tumor was snap 
frozen in liquid nitrogen and processed for immunohistochemisiry.
RNA Isolation and Northern Blotting. RNA was isolated according to 
Chomczynski and Sacehi (37). RNA was blotted, hybridized, and probed with 
32P-labeled cDNA fragments in 7% w/v SDS, 0.5 m  NaHP02 (pH 7.2), and 10 
mM EDTA at 65°C. Blots were routinely washed with 2 X  SSC, and 1% w/v 
SDS for 1 h at 65°C (I X  SSC = 0.15 m  NaCl and 0.015 m  sodium citrate). 
cDNA fragments were labeled using the random primer method (Megaprime; 
Amersham, United Kingdom), with [32P]dCTP (specific activity was approx­
imately 10° epm/^g DNA). The hybridization was quantified using a phos- 
phoimager (Fujix BAS 1000).
cDNA Probes, For the hybridization experiments, the following cDNA 
fragments were used as probes: a full-length fragment of the human RAP 
cDNA (16) and 6.0-kb fragment of the human LRP cDNA (38), both kindly 
provided by Dr. J. Herz, and a 1.2-kb fragment of the human GAPDH cDNA 
(39).
Melanocytic Lesions. Representative tissue samples were freshly received 
from cutaneous melanocytic lesions excised from patients at the University 
Hospital in Nijmegen, the Netherlands and from patients at the University 
Hospital in Wiizburg, Germany. They were snap frozen in liquid nitrogen and 
stored at -8 0 °C  until sectioning. Based on conventional histopathological 
examination of paraffin sections, 107 melanocytic lesions were divided into 
five classes: common NN (n = 22), AN {n = 12), ePM (Breslow thickness, 
<1.5 mm; (n = 10), aPM (Breslow thickness, s i . 5 mm; {n = 26), and MM 
{n = 37).
Antibodies. Two mouse monoclonal antibodies against LRP (3402 recog­
nizing the a  chain and 3501 recognizing the jQ chain) were obtained from 
American Diagnostica, Inc. (Greenwich, CT) and have been extensively char­
acterized, both by Western blotting and for their use in immunohistochemisiry 
(20). One rabbit polyclonal anti serum againsL RAP and its preimmune serum 
were prepared at the Gaubius Laboratory (Leiden, the Netherlands). A second 
rabbit polyclonal antiserum against RAP was generously provided by Dr. A. L. 
Schwartz (Department of Pediatrics, Washington University School of Medi­
cine, St. Louis, MO), and has been characterized and used in immunocyto- 
ehemistry before (24). NKI-bcteb, a mouse monoclonal antibody recognizing 
the melanosomal protein gplOO (40) was used to determine the melanocytic 
origin of the lesions. A polyclonal antibody against «-glucosidase, a lysosomal 
marker (a generous gift from Dr. J. Fransen, Department of Cell Biology and 
Histology) was used in double-labeling experiments.
Characterization and Testing of Antibodies, Antibodies against LRP and 
RAP were tested on frozen sections of placenta and liver, two organs known 
to express abundant LRP and RAP (20, 21, 25). Immunolocalization with both 
LRP antibodies and both RAP antibodies corresponded well.
Immunohistochemisiry. The immunohistochemical staining procedure for 
polyclonal antibodies was as described previously (2, 41). Antibody binding 
was visualized using 3-amino-9-cthylearbazole as a substrate for peroxidase. 
Consecutive sections of the same lesion were incubated with the anti- LRP 
antibodies and the anti-RAP antisera.
An incubation where the first antibody was omitted served as a negative 
control for the stainings with the monoclonal antibody, an incubation with a 
similar dilution of the preimmune serum served as a negative control for the 
RAP anti-sera.
Score. For each section, the percentage of positive melanocytic cells was 
estimated. Each section was assigned to one of the following categories: 0 %, 
1-5%, 5-25%, 25-50%, 50-75%, and 75-100% positivity. Positive melano­
cytic staining was registered when at least 1% of the melanocytic cells stained. 
Notes were taken of other staining components {e.g., fibroblastic cells) among 
the melanocytic areas.
Immunofluorescence Double Staining on Tissue Sections and Cells. We 
devised immunofluorescence double-labeling experiments to test whether LRP 
and RAP were expressed by the same cells. Thin 2-fim cryostat sections were 
cut from five melanoma metastasis lesions, comprising a variety of staining 
aspects (no tumor cells stained, scattered positivity, or all tumor cells stained) 
as judged from the AEC staining of the same cryostat blocks. Before staining, 
the sections were fixed in acetone for 10 min at room temperature.
To investigate the localization of LRP and RAP at the cellular level, we 
cultured IFfi and MV3 melanoma cells and human foreskin fibroblasts. Upon 
culturing on microscope slides, the slides were washed in serum-free DMEM 
and briefly fixed in acetone. Sections or cultured cells were incubated for 60
min with a mix of 3402 and anti-RAP rabbit antiserum in 1 % (w/v) BSA and 
washed in PBS. A mixture of FITC-labeled sheep antimouse immunoglobulin 
and TRITC-labeled swine antirabbit immunoglobulin (both from DAKO, 
Glostrup, Denmark) was applied for 30 min to detect LRP and RAP, respec­
tively. Upon washing in PBS, the sections were covered with glycerol con­
taining 25% (v/v) Vectashield (Vector Laboratories, Burlingame CA) and I 
/xg/ml 4',6-diamidino-2-phenylindole, counterstaining the nuclei. No fluores­
cence was seen when a combination of 3402 with TRITC-labeled swine 
antirabbit conjugate or a combination of rabbit anti-RAP with FITC-labeled 
sheep antimouse conjugate was applied on the sections or the cells. Alterna­
tively, double-labeling experiments combining mouse monoclonal NKI-beteb 
(a melanosomal marker) and RAP or 3402 with a rabbit anti-a-glucosidase (a 
lysosomal marker) were devised to show non-overlapping or partially over­
lapping epitopes on tissue sections and cultured cells.
Flow Cytometric Analysis. To determine cell surface expression of LRP 
and RAP on melanoma cell lines and human foreskin fibroblasts, subconfluent 
monolayers were briefly trypsinized, and 105 cells were incubated for 30 min 
at 4°C with either a dilution of mouse monoclonal antibody 3402 against LRP 
or with one of the two rabbit polyclonal anti-RAP sera in PBS containing 0.5% 
(w/v) BSA. The bound antibodies were detected using FITC-conjugated anti- 
mouse or antirabbit antibodies.
To determine the total presence of LRP and RAP, 105 briefly trypsinized 
cells were made permeable and fixed by incubating for 40 min at room 
temperature in PermeaFix (Ortho Diagnostic Systems, Inc., Bcerse, Belgium; 
see also Ref. 42). Upon washing in PBS/BSA, cells were incubated v/ith the 
specific antibodies following the procedure as described above. Incubation 
with a similar concentration of irrelevant antibody in the case of the mono­
clonal antibody or with a similar dilution of preimmune serum in the case of 
the two RAP anti sera served as negative controls.
FITC-labeled cells were analyzed on an Epics Elite flow cytometer 
(Coulter, Mijdrecht, the Netherlands).
RESULTS
LRP and RAP in Melanoma Cell Lines
mRNA Analysis. We analyzed the mRNA of the ceil lines for the 
presence of LRP and RAP mRNA, Northern blotting revealed that 
LRP and RAP mRNAs were expressed in all ceil lines (Fig. 1A). 
Relatively high levels of LRP mRNA and relatively low levels of 
RAP mRNA were found in BLM, MV3, and fibroblasts compared to 
the other cell lines (Table 1).
Flow Cytometry. Parallel to the mRNA analysis, we used flow 
cytometric analysis to investigate whether LRP and RAP are ex­
pressed on the cell surface of a panel of seven melanoma cell lines and 
fibroblasts. To get an impression of the total expression of LRP and 
RAP (e.g., cell surface + cytoplasmic expression), we also permeated 
and fixed cells prior to antibody labeling. LRP was expressed in the 
cytoplasm of all cell lines studied and on the cell surface of BLM, 
MV3, and fibroblasts. No cell surface expression of RAP was en­
countered. RAP was exclusively detected intracellularly in all cell 
lines at similar levels (Fig, 1B). Differences between the cell lines in 
mRNA content roughly coincide with the total protein measurement 
in the flow cytometric analysis (Fig. 1).







530 2.94 3.49 0.84
1F6 8.94 5.00 1.79
1 F6-m 2.62 2.62 1.00
M14 0.93 3.14 0.30
Mel57 3.13 2.46 1.27
MV3 5.16 1.17 4.42
BLM 7.33 1.61 4.54
Fibroblasts 2.13 0.42 5.06
a Relative intensities, corrected for the GAPDH mRNA intensity.
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LRP AND RAP IN MELANOMA
postulated recently that RAP functions as a chaperone or escort 
protein for LRP (15). RAP is found exclusively in the endoplasmatic 
reticulum (14). Hereby, RAP can prevent binding of other known 
ligands for LRP which are known to be localized in the same cell 
compartments during the secretion route (14, 15). Our findings that 
LRP and RAP strictly colocalize in intracellular granular cell struc­
tures support this chaperone hypothesis. Our colocalization agrees 
with similar colocalization reported for cultured glioblastoma cells 
(24) and in human trophoblasts (25). Using both confocal laser mi­
croscopy and immunoelcctronmicroscopy, Bu et al. (24) showed that 
LRP and RAP colocalize to a great extent, mainly in the Golgi 
complex and in the endoplasmatic reticulum and not in endosomes, 
which were LRP enriched. Clearly, our double-immunofluorescence 
experiments do not discriminate between subtle differences in local­
ization between LRP and RAP (e.g., cell surface expression and 
intracellular expression).
Our general conclusion from the present study is that LRP and RAP 
are coordinately expressed in human melanoma cell lines and in 
human melanocytic lesions ranging from common nevocellular nevi 
up to metastasis lesions. This coordinated expression was shown by 
the fact that: (a) the majority of lesions expressed equal percentages 
of LRP and RAP positive cells; (b) on adjacent sections, LRP-positive 
cells were present in identical areas as RAP-positive cells; (c) in 
immunofluorescence double staining on lesions, we could assign RAP 
and LRP positivity to the same ceils; and (d) in immunofluorescence 
double staining on cultured cells, this colocalization could be estab­
lished on the (sub)cellular level. Our results suggest a strict colocaL 
ization of LRP and RAP in cultured fibroblasts and melanoma cells, 
although RAP is absent on the cell membranes. The majority of LRP 
and RAP however, is localized intracellularly.
Since LRP and RAP expression is inversely correlated to the 
expression of many known ligands for LRP in melanoma tumor 
progression, it is interesting to speculate about the function of LRP 
and RAP in the benign lesions. Tn this respect, the discovery of new 
ligands for LRP such as components of the extracellular matrix (48) 
could shed new light on our observation that expression of LRP and 
RAP is decreased in melanocvtic tumor nroeression.
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